Medline (MDLN) said Thursday that certain selling stockholders closed an upsized secondary offering of 72.6 million shares of Class A common stock at $37.00 per share.
The selling stockholders also granted underwriters a 30-day option to purchase up to an additional 10.9 million shares.
Medline said it did not sell any shares in the offering and will not receive any proceeds.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.